| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Endocrinology and Diabetes (C.J., V.R.O., W.J.I., F.P.A.), St. Vincents Hospital, Melbourne 3065, Australia; Department of Medicine (C.J., R.J.D., W.J.I., F.P.A.), University of Melbourne, Melbourne 3010, Australia; and Laboratory of Molecular Hypertension (Z.K.), Baker Heart Research Institute, Melbourne 3004, Australia
Address all correspondence and requests for reprints to: Christina Jang, M.B., B.S., FRACP, Department of Endocrinology and Diabetes, St. Vincents Hospital, Melbourne, 41 Victoria Parade, Fitzroy 3065, Australia. E-mail: christina.jang{at}svhm.org.au.
Context: There is little information regarding the regulation of 11ß-hydroxysteroid dehydrogenase (11ß-HSD) enzymes in skeletal muscle in the setting of type 2 diabetes.
Objective: Our objective was to investigate whether there is differential mRNA expression and enzyme activity of 11ß-HSD1 and 11ß-HSD2 in the skeletal muscle of diabetic subjects compared with controls at baseline and in response to dexamethasone.
Design: Participants underwent muscle biopsy of vastus lateralis at baseline and after dexamethasone.
Setting: The study took place at a university teaching hospital.
Participants: Twelve subjects with type 2 diabetes and 12 age- and sex-matched controls participated.
Intervention: Subjects were given oral dexamethasone, 4 mg/d for 4 d.
Main Outcome Measures: We assessed 11ß-HSD1, 11ß-HSD2, and H6PDH mRNA levels by quantitative RT-PCR and enzyme activity by percent conversion of [3H]cortisone and [3H]cortisol, respectively.
Results: At baseline, mRNA levels were similar in diabetic and control subjects for 11ß-HSD1, 11ß-HSD2, and H6PDH. 11ß-HSD1 activity was reduced in diabetic subjects (percent conversion of [3H]cortisone to [3H]cortisol was 11.4 ± 2.5% vs. 18.5 ± 2.2%; P = 0.041), and 11ß-HSD2 enzyme activity was higher in diabetic subjects (percent conversion of [3H]cortisone to [3H]cortisol was 17.2 ± 2.6% vs. 9.2 ± 1.3%; P = 0.012). After dexamethasone, 11ß-HSD1 mRNA increased in both groups (P < 0.001), whereas 11ß-HSD2 mRNA decreased (P = 0.002). 11ß-HSD1 activity increased in diabetic subjects (P = 0.021) but not in controls, whereas 11ß-HSD2 activity did not change in either group. At baseline, there was a significant negative correlation between 11ß-HSD1 and 11ß-HSD2 enzyme activity (r = –0.463; P = 0.026).
Conclusions: The activities of skeletal muscle 11ß-HSD1 and 11ß-HSD2 are altered in diabetes, which together may reduce intracellular cortisol generation, potentially conferring metabolic protection.
This article has been cited by other articles:
![]() |
S. A. Morgan, M. Sherlock, L. L. Gathercole, G. G. Lavery, C. Lenaghan, I. J. Bujalska, D. Laber, A. Yu, G. Convey, R. Mayers, et al. 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Regulates Glucocorticoid-Induced Insulin Resistance in Skeletal Muscle Diabetes, November 1, 2009; 58(11): 2506 - 2515. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jang, V. R Obeyesekere, F. P Alford, and W. J Inder Skeletal muscle 11{beta} hydroxysteroid dehydrogenase type 1 activity is upregulated following elective abdominal surgery Eur. J. Endocrinol., February 1, 2009; 160(2): 249 - 255. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |